Professional Documents
Culture Documents
Hypertension 1
Hypertension 1
•An estimated 1.13 billion people worldwide have hypertension, most (two-thirds)
living in low- and middle-income countries.
•One of the global targets for non communicable diseases is to reduce the prevalence
of hypertension by 25% by 2025.
What are the risk factors for hypertension?
Most people with hypertension are unaware of the problem because it may have
no warning signs or symptoms.
Early morning headaches, nosebleeds, irregular heart rhythms, vision changes,
and buzzing in the ears.
Severe hypertension can cause fatigue, nausea, vomiting, confusion, anxiety,
chest pain, and muscle tremors. The only way to detect hypertension is to have a
health professional measure blood pressure.
Individuals can also measure their own blood pressure using automated devices,
however, an evaluation by a health professional is important for assessment of
risk and associated conditions.
What are the complications of uncontrolled hypertension?
Reducing hypertension prevents heart attack, stroke, and kidney damage, as well as other health
problems
Prevention
•Reducing salt intake (to less than 5g daily)
•Eating more fruit and vegetables
•Being physically active on a regular basis
•Avoiding use of tobacco
•Reducing alcohol consumption
•Limiting the intake of foods high in saturated fats
•Eliminating/reducing trans fats in diet
Management
In 2016, WHO and the United States Centers for Disease Control and Prevention
launched the Global Hearts Initiative to support governments to prevent and
treat cardiovascular diseases.
HEARTS technical package aims to improve the prevention and management of
cardiovascular diseases
The five modules of the HEARTS technical package (Healthy-lifestyle counselling,
Evidence-based treatment protocols, Access to essential medicines and technology,
Team-based care, and Systems for monitoring) provide a strategic approach to
improve cardiovascular health in countries across the globe.
Fifteen countries have started implementing the HEARTS technical
package (Barbados, Bhutan, Colombia, Chile, China, Cuba, Ethiopia,
India, Iran, Morocco, Nepal, Philippines, Tajikistan, Thailand, and
Viet Nam). By scaling up protocol-based management, improving
access to medicines and technologies, and better measuring
outcomes, successes are already being achieved.
Renin
angiotensin
aldosterone
system